Opioids

Simple item page
dc.contributor.advisorTasian, Gregory
dc.contributor.authorMaltenfort, Mitchell
dc.contributor.otherChildren's Hospital of Philadelphia
dc.date.accessioned2024-06-10T19:03:15Z
dc.date.available2024-06-10T19:03:15Z
dc.date.created2021-09-08
dc.descriptionThis medication concept set includes the following opioids: tilidine, tramadol, buprenorphine, butorphanol, dezocine, codeine, fentanyl, dihydrocodeine, morphine, hydromorphone, Ketobemidone, meperidine, methadone, nalbuphine, opium, oxycodone, papaveretum, pentazocine, pirinitramide, propoxyphene, or tapentadol. The concept set was re-used from prior work in a PKIDS study for work investigating sickle cell disease. The code set is a part of a clinical variable definition for inpatient hospitalization. To be classified with pain hospitalization, a patient needs to have a tleast one occurrence of diagnosis code in the inpatient visit OR two exposures to opioids on separate days. Face validity was checked using manual review on a small subset of patient. 100% specificity and sensitivities were seen.
dc.description.abstractConcept set intended to identify patients with an exposure to opioids.
dc.identifier.urihttps://pedsnet.org/metadata/handle/20.500.14642/424
dc.language.isoen-US
dc.provenanceThis concept set was first used as part of the Outcomes of Children with Kidney Stones: Retrospective Cohort Study. The concept set was then re-used in 2024 for Impact of the 2014 NHLBI Guidelines on Cerebrovascular Events in Sickle Cell Disease to identify sickle cell patients with hospitalizations for pain.
dc.publisherPEDSnet
dc.relation.urihttps://atlassian.chop.edu/bitbucket/projects/PRP/repos/pkids_stone/browse
dc.rightsa CC-BY Attribution 4.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectConcept Set Development::Content Data Model::PEDSnet Data Model
dc.subjectConcept Set Development::Concept Set Development Strategy::Variable Characterization::Dependent Variable
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name
dc.subjectConcept Set Development::Concept Set Development Strategy::Variable Characterization::Covariate
dc.subjectConcept Set Development::Concept Set Evaluation::Chart Reviewed
dc.subjectConcept Set Development::Concept Set Evaluation::Validated
dc.subject.meshOpioid Agonist
dc.subject.meshReceptor Agonist
dc.subject.meshNervous System Agent
dc.subject.otherRxNorm
dc.subject.otherRxNorm Extension
dc.titleOpioids
dspace.entity.typeConceptSet
local.quality.statusNeeds Refinement
local.subject.flatPEDSnet Data Model
local.subject.flatBrand Pack Name
local.subject.flatCovariate Variable
local.subject.flatClinician Reviewed
relation.isStudyOfConceptSet91df2977-0eb2-4c61-be85-7075d3b8e8d4
relation.isStudyOfConceptSet0b4b2fe5-e52b-4a0b-b0b1-6c493f8efe40
relation.isStudyOfConceptSet.latestForDiscovery91df2977-0eb2-4c61-be85-7075d3b8e8d4

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rx_2021_09_Opioids_V1.csv
Size:
5.75 MB
Format:
Comma-Separated Values
Download

Domains

Medication Concept Sets